Investing Ideas
/
US Transformative Artificial intelligence (AI) Healthcare Stocks

US Transformative Artificial intelligence (AI) Healthcare Stocks

Results

1 new

Artificial intelligence (AI) is set to transform healthcare by enhancing diagnostics, personalizing medicine, boosting operational efficiency, expanding remote care, and accelerating research. AI outperforms humans in detecting diseases like cancer from scans, tailors treatments using genetic and lifestyle data, and streamlines hospital workflows with tools like predictive analytics and automated transcription. It powers telemedicine, monitors chronic conditions in real-time, and speeds up drug discovery by analyzing vast datasets for insights into complex diseases. Despite challenges like data privacy, bias, and integration costs, AI’s ability to improve accuracy, access, and affordability could save billions and extend lives, marking a seismic shift in healthcare delivery and outcomes.

25 companies

Cosmo Pharmaceuticals

Market Cap: US$906.6m

Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.

CMOP.F

US$65.80

-10.5%

-10.1%

Nano-X Imaging

Market Cap: US$354.1m

Develops a commercial-grade tomographic imaging device with a digital X-ray source.

NNOX

US$6.05

6.3%

-36.1%

Predictive Oncology

Market Cap: US$7.4m

A knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies.

POAI

US$1.11

-0.9%

-58.4%

Spectral AI

Market Cap: US$33.2m

An artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States.

MDAI

US$1.70

9.7%

-27.4%

Evaxion Biotech

Market Cap: US$11.8m

A clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies.

EVAX

US$1.89

6.2%

-87.6%

Acarix

Market Cap: US$276.6m

A medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out.

ACIX.F

US$0.03

8.9%

13.4%

Healwell AI

Market Cap: US$280.3m

A healthcare technology company, focuses on AI and data science for preventative care.

HWAI.F

US$1.14

13.2%

63.0%

ImmunoPrecise Antibodies

Market Cap: US$19.4m

A biotechnology company that leverages multi-omics modeling and artificial intelligence through a series proprietary and patented technologies.

IPA

US$0.42

10.0%

-73.0%

Simulations Plus

Market Cap: US$513.6m

Develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide.

SLP

US$25.56

-2.0%

-40.5%

Lantheus Holdings

Market Cap: US$6.7b

Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.

LNTH

US$97.71

-3.4%

65.6%

iCAD

Market Cap: US$58.8m

Engages in the provision of cancer detection and therapy solutions in the United States.

New

ICAD

US$2.23

-2.6%

39.4%

Tempus AI

Market Cap: US$8.8b

Operates as a healthcare technology company.

TEM

US$51.35

8.9%

n/a

RadNet

Market Cap: US$3.6b

Provides outpatient diagnostic imaging services in the United States and internationally.

RDNT

US$49.25

5.8%

2.5%

CareCloud

Market Cap: US$63.9m

A healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States.

CCLD

US$1.51

2.7%

31.3%

Guerbet

Market Cap: US$204.5m

Engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions.

GUER.F

US$22.25

n/a

BioXcel Therapeutics

Market Cap: US$7.2m

A commercial-stage biopharmaceutical company, engages in utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology.

BTAI

US$2.33

9.4%

-94.8%

Premier

Market Cap: US$1.7b

Operates as a healthcare improvement company in the United States.

PINC

US$18.55

2.1%

-14.7%

Ontrak

Market Cap: US$6.5m

Operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States.

OTRK

US$1.55

7.6%

-73.6%

HeartSciences

Market Cap: US$3.1m

A medical technology company, focuses on applying AI-based technology to an ECG to enhance its clinical utility.

HSCS

US$2.91

-0.9%

-75.8%

Perimeter Medical Imaging AI

Market Cap: US$52.4m

A medical technology company, provides advanced imaging tools that address unmet medical needs.

PYNK.F

US$0.40

11.6%

-35.8%

CeriBell

Market Cap: US$732.4m

Operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States.

CBLL

US$20.42

-2.9%

n/a

OmniAb

Market Cap: US$309.0m

A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.

OABI

US$2.53

-23.6%

-50.7%

BioSig Technologies

Market Cap: US$9.4m

A medical technology company, focuses on deciphering the body’s electrical signals starting with heart rhythms.

BSGM

US$0.55

-11.1%

1.1%

Absci

Market Cap: US$383.3m

Operates as a data-first generative artificial intelligence (AI) drug creation company in the United States.

ABSI

US$3.01

-4.1%

-39.2%

Aspira Women's Health

Market Cap: US$1.5m

Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States.

AWH

US$0.088

-37.2%

-97.6%

Page 1 of 1